{"id":2404,"date":"2026-03-20T10:00:00","date_gmt":"2026-03-20T10:00:00","guid":{"rendered":"https:\/\/livingdiabetes.com\/?p=2404"},"modified":"2026-03-11T01:52:44","modified_gmt":"2026-03-11T01:52:44","slug":"cholesterol-and-diabetes-your-complete-guide-to-diabetic-dyslipidaemia","status":"publish","type":"post","link":"https:\/\/livingdiabetes.com\/ur\/cholesterol-and-diabetes-your-complete-guide-to-diabetic-dyslipidaemia\/","title":{"rendered":"Cholesterol and Diabetes: Your Complete Guide to Diabetic Dyslipidaemia"},"content":{"rendered":"
\n

Diabetes profoundly disrupts cholesterol metabolism in ways not always reflected in a standard cholesterol test. Even when total cholesterol appears normal, people with diabetes often have a particularly dangerous lipid profile \u2014 one that significantly accelerates cardiovascular disease. Understanding “diabetic dyslipidaemia” is essential for protecting your heart.<\/p>\n<\/div>\n

What Is Diabetic Dyslipidaemia?<\/h2>\n

Diabetic dyslipidaemia is characterised by three hallmark features: elevated triglycerides, low HDL cholesterol, and the presence of small, dense LDL particles. This triad is far more atherogenic than elevated LDL alone. Insulin resistance impairs lipoprotein lipase, leading to elevated VLDL production and reduced HDL levels. The resulting small, dense LDL particles penetrate arterial walls more easily and are more susceptible to oxidation.<\/p>\n

\u26a0\ufe0f Cholesterol Targets for People with Diabetes<\/strong><\/p>\n\n\n\n\n\n
Lipid Parameter<\/th>\nHigh CV Risk<\/th>\nVery High CV Risk<\/th>\n<\/tr>\n
LDL Cholesterol<\/strong><\/td>\n<70 mg\/dL<\/td>\n<55 mg\/dL<\/td>\n<\/tr>\n
Triglycerides<\/strong><\/td>\n<150 mg\/dL<\/td>\n<150 mg\/dL<\/td>\n<\/tr>\n
HDL Cholesterol<\/strong><\/td>\n>40 mg\/dL (men); >50 mg\/dL (women)<\/td>\nHigher is better<\/td>\n<\/tr>\n<\/table>\n<\/div>\n

Statin Therapy: The Cornerstone of Treatment<\/h2>\n

Current ADA guidelines recommend statin therapy for all adults with diabetes aged 40\u201375 years, regardless of LDL level. Multiple large trials \u2014 including the Heart Protection Study and CARDS \u2014 have demonstrated that statin therapy reduces major cardiovascular events by 20\u201337% in people with diabetes. For those with established cardiovascular disease, high-intensity statin therapy (atorvastatin 40\u201380 mg or rosuvastatin 20\u201340 mg) is recommended.<\/p>\n

\u2705 Dietary Changes That Improve Cholesterol<\/strong><\/p>\n